Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Placebo-controlled, Double-blind Clinical Trial: The Efficacy and Safety of Mexiletine Hydrochloride for Amelioration of Motor Dysfunction in Spinal and Bulbar Muscular Atrophy

NCT06862596 is registered in ClinicalTrials.gov with Masahisa Katsuno as lead sponsor.

NCT NCT06862596
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06862596 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Placebo-controlled, Double-blind Clinical Trial: The Efficacy and Safety of Mexiletine Hydrochloride for Amelioration of Motor Dysfunction in Spinal and Bulbar Muscular Atrophy
Lead sponsor
Masahisa Katsuno
Phase
Phase 2/3
Overall status
Recruiting
Start date
February 28, 2025
Completion date
December 31, 2027
Enrollment
68 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

spinal and bulbar muscular atrophy